References
- Khadangi F, Azzi A. Vitamin E – the next 100 years. IUBMB Life. 2019;71(4):411–5. doi:https://doi.org/10.1002/iub.1990
- Jiang Q. Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med. 2014;72:76–90. doi:https://doi.org/10.1016/j.freeradbiomed.2014.03.035
- Miyazawa T, Burdeos GC, Itaya M, Nakagawa K, Miyazawa T. Vitamin E: regulatory redox interactions. IUBMB Life. 2019;71(4):430–41. doi:https://doi.org/10.1002/iub.2008
- Traber MG, Leonard SW, Bobe G, Fu X, Saltzman E, Grusak MA, Booth SL. α-Tocopherol disappearance rates from plasma depend on lipid concentrations: Studies using deuterium-labeled collard greens in younger and older adults. Am J Clin Nutr. 2015;101(4):752–9. doi:https://doi.org/10.3945/ajcn.114.100966
- Abraham A, Kattoor AJ, Saldeen T, Mehta JL. Vitamin E and its anticancer effects. Crit Rev Food Sci Nutr. 2019;59(17):2831–8. doi:https://doi.org/10.1080/10408398.2018.1474169
- Jiang Q. Natural forms of vitamin E as effective agents for cancer prevention and therapy. Adv Nutr. 2017;8(6):850–67. doi:https://doi.org/10.3945/an.117.016329
- Yu W, Jia L, Park S-K, Li J, Gopalan A, Simmons-Menchaca M, Sanders BG, Kline K. Anticancer actions of natural and synthetic vitamin E forms: RRR-alpha-tocopherol blocks the anticancer actions of gamma-tocopherol. Mol Nutr Food Res. 2009;53(12):1573–81. doi:https://doi.org/10.1002/mnfr.200900011
- Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, et al. Vitamin E and the risk of prostate cancer: The selenium and Vitamin E cancer prevention trial (SELECT). JAMA. 2011;306(14):1549–56., doi:https://doi.org/10.1001/jama.2011.1437
- Lee I-M, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. Vitamin E in the primary prevention of cardiovascular disease and cancer: the women’s health study: A randomized controlled trial. JAMA. 2005;294(1):56–65. doi:https://doi.org/10.1001/jama.294.1.56
- Yang CS, Luo P, Zeng Z, Wang H, Malafa M, Suh N. Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienols. Mol Carcinog. 2020;59(4):365–89. doi:https://doi.org/10.1002/mc.23160
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016;293(2):247–69. doi:https://doi.org/10.1007/s00404-015-3859-y
- Schwarz-Cruz YCA, Espinosa M, Maldonado V, Melendez-Zajgla J. Advances in the knowledge of breast cancer stem cells. A review. Histol Histopathol. 2016;31:601–12.
- Li W, Ma H, Zhang J, Zhu L, Wang C, Yang Y. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Sci Rep. 2017;7(1):13856. doi:https://doi.org/10.1038/s41598-017-14364-2
- Bak MJ, Furmanski P, Shan NL, Lee HJ, Bao C, Lin Y, Shih WJ, Yang CS, Suh N. Tocopherols inhibit estrogen-induced cancer stemness and OCT4 signaling in breast cancer. Carcinogenesis. 2018;39(8):1045–55. doi:https://doi.org/10.1093/carcin/bgy071
- Idriss M, Hodroj MH, Fakhoury R, Rizk S. Beta-tocotrienol exhibits more cytotoxic effects than gamma-tocotrienol on breast cancer cells by promoting apoptosis via a P53-independent PI3-kinase dependent pathway. Biomolecules. 2020;10(4):577. doi:https://doi.org/10.3390/biom10040577
- Wei CW, Yu YL, Chen YH, Hung YT, Yiang GT. Anticancer effects of methotrexate in combination with α‑tocopherol and α‑tocopherol succinate on triple‑negative breast cancer. Oncol Rep. 2019;41(3):2060–6. doi:https://doi.org/10.3892/or.2019.6958
- Wei C-W, Yu Y-L, Lu J-Y, Hung Y-T, Liu H-C, Yiang G-T. Anti-cancer effects of sulfasalazine and vitamin E succinate in MDA-MB 231 triple-negative breast cancer cells. Int J Med Sci. 2019;16(4):494–500. doi:https://doi.org/10.7150/ijms.30380
- Wu Y, Liu J, Movahedi F, Gu W, Xu T, Xu ZP. Enhanced prevention of breast tumor metastasis by nanoparticle-delivered vitamin E in combination with interferon-gamma. Adv Healthc Mater. 2020;9(6):e1901706. doi:https://doi.org/10.1002/adhm.201901706
- Playdon MC, Ziegler RG, Sampson JN, Stolzenberg-Solomon R, Thompson HJ, Irwin ML, Mayne ST, Hoover RN, Moore SC. Nutritional metabolomics and breast cancer risk in a prospective study. Am J Clin Nutr. 2017;106(2):637–49. doi:https://doi.org/10.3945/ajcn.116.150912
- Suhail N, Bilal N, Khan HY, Hasan S, Sharma S, Khan F, Mansoor T, Banu N. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy. J Clin Pharm Ther. 2012;37(1):22–6. doi:https://doi.org/10.1111/j.1365-2710.2010.01237.x
- Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, et al. Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). JCO. 2020;38(8):804–14.: doi:https://doi.org/10.1200/JCO.19.01203
- Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. doi:https://doi.org/10.1016/S2214-109X(19)30482-6
- Barchitta M, Maugeri A, La Mastra C, La Rosa MC, Favara G, Magnano San Lio R, Agodi A. Dietary antioxidant intake and human papillomavirus infection: Evidence from a cross-sectional study in Italy. Nutrients. 2020;12(5):1384. doi:https://doi.org/10.3390/nu12051384
- Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutr Cancer. 2008;60(3):331–41. doi:https://doi.org/10.1080/01635580701861769
- Kim J, Kim MK, Lee JK, Kim J-H, Son SK, Song E-S, Lee KB, Lee JP, Lee JM, Yun YM, et al. Intakes of vitamin A, C, and E, and beta-carotene are associated with risk of cervical cancer: A case-control study in Korea. Nutr Cancer. 2010;62(2):181–9. doi:https://doi.org/10.1080/01635580903305326
- Zhang YY, Lu L, Abliz G, Mijit F. Serum carotenoid, retinol and tocopherol concentrations and risk of cervical cancer among Chinese women. Asian Pac J Cancer Prev. 2015;16(7):2981–6. doi:https://doi.org/10.7314/apjcp.2015.16.7.2981
- Hu X, Li S, Zhou L, Zhao M, Zhu X. Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies. PLoS One. 2017;12(8):e0183395. doi:https://doi.org/10.1371/journal.pone.0183395
- Petropoulos SA, Fernandes Â, Dias MI, Pereira C, Calhelha R, Di Gioia F, Tzortzakis N, Ivanov M, Sokovic M, Barros L, et al. Wild and cultivated Centaurea raphanina subsp. mixta: A valuable source of bioactive compounds. Antioxidants (Basel). 2020;9(4):314.: doi:https://doi.org/10.3390/antiox9040314
- Xu W, Mi Y, He P, He S, Niu L. γ-Tocotrienol inhibits proliferation and induces apoptosis via the mitochondrial pathway in human cervical cancer HeLa cells. Molecules. 2017;22:1299.
- Sailo BL, Banik K, Padmavathi G, Javadi M, Bordoloi D, Kunnumakkara AB. Tocotrienols: The promising analogues of vitamin E for cancer therapeutics. Pharmacol Res. 2018;130:259–72. doi:https://doi.org/10.1016/j.phrs.2018.02.017
- Wang Y, Zuo A, Huang X, Ying Y, Shu X, Chen X, Yang Y, Ma J, Lin G, Wang X, et al. Docetaxel-loaded PAMAM-based poly (γ-benzyl-L-glutamate)-b-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy. J Microencapsul. 2019;36(6):552–65. doi:https://doi.org/10.1080/02652048.2019.1654002
- Felix AS, Yang HP, Bell DW, Sherman ME. Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences. Adv Exp Med Biol. 2017;943:3–46. doi:https://doi.org/10.1007/978-3-319-43139-0_1
- Espinosa I, De Leo A, D’Angelo E, Rosa-Rosa JM, Corominas M, Gonzalez A, Palacios J, Prat J. Dedifferentiated endometrial carcinomas with neuroendocrine features: A clinicopathologic, immunohistochemical, and molecular genetic study. Hum Pathol. 2018;72:100–6. doi:https://doi.org/10.1016/j.humpath.2017.11.006
- Koshiyama M. The effects of the dietary and nutrient intake on gynecologic cancers. Healthcare (Basel) 2019;7(3):88. doi:https://doi.org/10.3390/healthcare7030088
- Xu W-H, Dai Q, Xiang Y-B, Zhao G-M, Ruan Z-X, Cheng J-R, Zheng W, Shu XO. Nutritional factors in relation to endometrial cancer: A report from a population-based case-control study in Shanghai, China. Int J Cancer. 2007;120(8):1776–81. doi:https://doi.org/10.1002/ijc.22456
- Bandera EV, Gifkins DM, Moore DF, McCullough ML, Kushi LH. Antioxidant vitamins and the risk of endometrial cancer: A dose-response meta-analysis. Cancer Causes Control. 2009;20(5):699–711. doi:https://doi.org/10.1007/s10552-008-9283-x
- Gifkins D, Olson SH, Demissie K, Lu S-E, Kong A-NT, Bandera EV. Total and individual antioxidant intake and endometrial cancer risk: Results from a population-based case-control study in New Jersey. Cancer Causes Control. 2012;23(6):887–95. doi:https://doi.org/10.1007/s10552-012-9958-1
- Heublein S, Vrekoussis T, Etzl R, Rotzoll D, Kuhn C, Faigle G, Navrozoglou I, Stefos T, Makrigiannakis A, Jeschke U, et al. Alpha tocopherol transfer protein (αTTP) is expressed in endometrial carcinoma and is correlated with FIGO stage and 5-year survival. J Cancer Res Clin Oncol. 2017;143(5):773–81. doi:https://doi.org/10.1007/s00432-017-2340-7
- Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3–14. doi:https://doi.org/10.1016/j.bpobgyn.2016.08.006
- Colombo N, Sessa C, Du Bois A, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, ESMO-ESGO Ovarian Cancer Consensus Conference Working Group, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol. 2019;30(5):672–705. doi:https://doi.org/10.1093/annonc/mdz062
- Koushik A, Wang M, Anderson KE, van den Brandt P, Clendenen TV, Eliassen AH, Freudenheim JL, Genkinger JM, Håkansson N, Marshall JR, et al. Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies. Cancer Causes Control. 2015;26(9):1315–27. doi:https://doi.org/10.1007/s10552-015-0626-0
- Leng Y, Zhou H, Meng F, Tian T, Xu J, et al. Association of vitamin E on the risk of ovarian cancer: A meta-analysis. Biosci Rep. 2019;39:BSR20193311.
- Bidoli E, La Vecchia C, Talamini R, Negri E, Parpinel M, Conti E, Montella M, Carbone MA, Franceschi S. Micronutrients and ovarian cancer: A case-control study in Italy. Ann Oncol. 2001;12(11):1589–93. doi:https://doi.org/10.1023/a:1013124112542
- Bermudez Y, Ahmadi S, Lowell NE, Kruk PA. Vitamin E suppresses telomerase activity in ovarian cancer cells. Cancer Detect Prev. 2007;31(2):119–28. doi:https://doi.org/10.1016/j.cdp.2006.12.002
- Jeong N-H, Song E-S, Lee J-M, Lee K-B, Kim M-K, Cheon J-E, Lee J-K, Son S-K, Lee J-P, Kim J-H, et al. Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer. Acta Obstet Gynecol Scand. 2009;88(4):457–62. doi:https://doi.org/10.1080/00016340902807215
- Guo Y, Lu Y, Jin H. Appraising the role of circulating concentrations of micro-nutrients in epithelial ovarian cancer risk: A Mendelian randomization analysis. Sci Rep. 2020;10(1):7356. doi:https://doi.org/10.1038/s41598-020-63909-5
- Thomsen CB, Andersen RF, Steffensen KD, Adimi P, Jakobsen A. Delta tocotrienol in recurrent ovarian cancer. A phase II trial. Pharmacol Res. 2019;141:392–6. doi:https://doi.org/10.1016/j.phrs.2019.01.017